Advertisement
Screener

NRC Health (NRC) Cash and Cash Equivalents, Period Increase (Decrease)

NRC Health Cash and Cash Equivalents, Period Increase (Decrease)

NRC Health (NRC) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.50 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-08

  • NRC Health cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$3.50M.
  • NRC Health cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $5.16M, a 9.78% decline year-over-year.
  • NRC Health cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $4.34M, a 654.43% increase year-over-year.
  • NRC Health cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $1.38M.
  • NRC Health cash and cash equivalents, period increase (decrease) for fiscal 2019 was $526.00K.
  • NRC Health cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$21.74M, a 1369.98% decline from fiscal 2017.
  • NRC Health cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.71M.
  • NRC Health cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$9.12M, a 533.86% decline from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2020-03-31-$3.50M
10-Q · filed 2020-05-08
$1.66M
derived: sum of 2 quarters · filed 2020-05-08
$6.00M
derived: sum of 3 quarters · filed 2020-05-08
$7.38M
derived: sum of 4 quarters · filed 2020-05-08
2019-12-31$5.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$9.50M
derived: sum of 2 quarters · filed 2020-03-06
$10.88M
derived: sum of 3 quarters · filed 2020-03-06
$526.00K
10-K · filed 2020-03-06
2019-09-30$4.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$5.72M
derived: sum of 2 quarters · filed 2019-11-08
-$4.63M
10-Q · filed 2019-11-08
$1.08M
derived: sum of 4 quarters · filed 2020-05-08
2019-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$8.97M
10-Q · filed 2019-08-08
-$3.25M
derived: sum of 3 quarters · filed 2020-05-08
-$2.68M
derived: sum of 4 quarters · filed 2020-05-08
2019-03-31-$10.35M
10-Q · filed 2020-05-08
-$4.63M
derived: sum of 2 quarters · filed 2020-05-08
-$4.06M
derived: sum of 3 quarters · filed 2020-05-08
-$32.84M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$5.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$6.29M
derived: sum of 2 quarters · filed 2020-03-06
-$22.49M
derived: sum of 3 quarters · filed 2020-03-06
-$21.74M
10-K · filed 2020-03-06
2018-09-30$575.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$28.20M
derived: sum of 2 quarters · filed 2019-11-08
-$27.46M
10-Q · filed 2019-11-08
-$28.48M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30-$28.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$28.04M
10-Q · filed 2019-08-08
-$29.05M
derived: sum of 3 quarters · filed 2020-03-06
-$24.93M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$745.00K
10-Q · filed 2019-05-08
-$272.00K
derived: sum of 2 quarters · filed 2020-03-06
$3.85M
derived: sum of 3 quarters · filed 2020-03-06
$814.00K
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$3.10M
derived: sum of 2 quarters · filed 2020-03-06
$69.00K
derived: sum of 3 quarters · filed 2020-03-06
$1.71M
10-K · filed 2020-03-06
2017-09-30$4.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$1.09M
derived: sum of 2 quarters · filed 2018-11-08
$2.73M
10-Q · filed 2018-11-08
$6.87M
derived: sum of 4 quarters · filed 2019-03-08
2017-06-30-$3.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$1.39M
10-Q · filed 2018-08-09
$2.75M
derived: sum of 3 quarters · filed 2019-03-08
$4.44M
derived: sum of 4 quarters · filed 2019-03-08
2017-03-31$1.64M
10-Q · filed 2018-05-04
$5.79M
derived: sum of 2 quarters · filed 2019-03-08
$7.47M
derived: sum of 3 quarters · filed 2019-03-08
$9.30M
derived: sum of 4 quarters · filed 2019-03-08
2016-12-31$4.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08
$5.83M
derived: sum of 2 quarters · filed 2019-03-08
$7.66M
derived: sum of 3 quarters · filed 2019-03-08
-$9.12M
10-K · filed 2019-03-08
2016-09-30$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$3.51M
derived: sum of 2 quarters · filed 2017-11-09
-$13.27M
10-Q · filed 2017-11-09
-$8.70M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$14.95M
10-Q · filed 2017-08-04
-$10.39M
derived: sum of 3 quarters · filed 2018-03-14
-$13.36M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31-$16.78M
10-Q · filed 2017-05-05
-$12.21M
derived: sum of 2 quarters · filed 2018-03-14
-$15.19M
derived: sum of 3 quarters · filed 2018-03-14
-$11.64M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$4.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$1.59M
derived: sum of 2 quarters · filed 2018-03-14
$5.13M
derived: sum of 3 quarters · filed 2018-03-14
$2.10M
10-K · filed 2018-03-14
2015-09-30-$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$570.00K
derived: sum of 2 quarters · filed 2016-11-04
-$2.46M
10-Q · filed 2016-11-04
-$1.48M
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30$3.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$513.00K
10-Q · filed 2016-08-05
$1.49M
derived: sum of 3 quarters · filed 2017-03-03
$9.02M
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31-$3.03M
10-Q · filed 2016-05-06
-$2.05M
derived: sum of 2 quarters · filed 2017-03-03
$5.47M
derived: sum of 3 quarters · filed 2017-03-03
$10.56M
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31$979.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
$8.50M
derived: sum of 2 quarters · filed 2017-03-03
$13.59M
derived: sum of 3 quarters · filed 2017-03-03
$17.95M
10-K · filed 2017-03-03
2014-09-30$7.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$12.61M
derived: sum of 2 quarters · filed 2015-11-05
$16.97M
10-Q · filed 2015-11-05
$20.13M
derived: sum of 4 quarters · filed 2016-03-04
2014-06-30$5.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$9.45M
10-Q · filed 2015-08-06
$12.61M
derived: sum of 3 quarters · filed 2016-03-04
$20.74M
derived: sum of 4 quarters · filed 2016-03-04
2014-03-31$4.36M
10-Q · filed 2015-05-08
$7.52M
derived: sum of 2 quarters · filed 2016-03-04
$15.65M
derived: sum of 3 quarters · filed 2016-03-04
$17.22M
derived: sum of 4 quarters · filed 2016-03-04
2013-12-31$3.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04
$11.29M
derived: sum of 2 quarters · filed 2016-03-04
$12.86M
derived: sum of 3 quarters · filed 2016-03-04
$13.81M
10-K · filed 2016-03-04
2013-09-30$8.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$9.70M
derived: sum of 2 quarters · filed 2014-11-07
$10.65M
10-Q · filed 2014-11-07
$3.91M
derived: sum of 4 quarters · filed 2015-03-04
2013-06-30$1.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
$2.52M
10-Q · filed 2014-08-06
-$4.22M
derived: sum of 3 quarters · filed 2015-03-04
-$366.00K
derived: sum of 4 quarters · filed 2015-03-04
2013-03-31$948.00K
10-Q · filed 2014-05-08
-$5.79M
derived: sum of 2 quarters · filed 2015-03-04
-$1.93M
derived: sum of 3 quarters · filed 2015-03-04
$1.36M
derived: sum of 4 quarters · filed 2015-03-04
2012-12-31-$6.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04
-$2.88M
derived: sum of 2 quarters · filed 2015-03-04
$414.00K
derived: sum of 3 quarters · filed 2015-03-04
$204.00K
10-K · filed 2015-03-04
2012-09-30$3.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$7.15M
derived: sum of 2 quarters · filed 2013-11-07
$6.94M
10-Q · filed 2013-11-07
$8.80M
derived: sum of 4 quarters · filed 2014-03-04
2012-06-30$3.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$3.09M
10-Q · filed 2013-08-08
$4.95M
derived: sum of 3 quarters · filed 2014-03-04
$6.70M
derived: sum of 4 quarters · filed 2014-03-04
2012-03-31-$210.00K
10-Q · filed 2013-05-08
$1.65M
derived: sum of 2 quarters · filed 2014-03-04
$3.41M
derived: sum of 3 quarters · filed 2014-03-04
$4.56M
derived: sum of 4 quarters · filed 2014-03-04
2011-12-31$1.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04
$3.62M
derived: sum of 2 quarters · filed 2014-03-04
$4.77M
derived: sum of 3 quarters · filed 2014-03-04
$4.56M
10-K · filed 2014-03-04
2011-09-30$1.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$2.91M
derived: sum of 2 quarters · filed 2012-11-07
$2.70M
10-Q · filed 2012-11-07
$3.03M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
$945.00K
10-Q · filed 2012-08-10
$1.27M
derived: sum of 3 quarters · filed 2013-03-01
-$2.77M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31-$203.00K
10-Q · filed 2012-05-11
$121.00K
derived: sum of 2 quarters · filed 2013-03-01
-$3.92M
derived: sum of 3 quarters · filed 2013-03-01
2010-12-31$324.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
-$3.72M
derived: sum of 2 quarters · filed 2013-03-01
$1.01M
10-K · filed 2013-03-01
2010-09-30-$4.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$683.00K
10-Q · filed 2011-11-08
2010-06-30$4.72M
10-Q · filed 2011-08-12
2009-12-31$1.40M
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14